Dow Today: UnitedHealth Group (UNH) Higher

The Dow Jones Industrial Average ( ^DJI) is trading up 84 points (+0.6%) at 15,219 as of Monday, Jul 8, 2013, 11:35 a.m. ET. During this time, 172.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 616.5 million. The NYSE advances/declines ratio sits at 2,029 issues advancing vs. 904 declining with 96 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be UnitedHealth Group (NYSE: UNH), which is sporting an 86-cent gain (+1.3%) bringing the stock to $67.03. This single gain is lifting the Dow Jones Industrial Average by 6.51 points or roughly accounting for 7.8% of the Dow's overall gain. Volume for UnitedHealth Group currently sits at 1.9 million shares traded vs. an average daily trading volume of 5.4 million shares.

UnitedHealth Group has a market cap of $66.85 billion and is part of the health care sector and health services industry. Shares are up 22% year to date as of Friday's close. The stock's dividend yield sits at 1.7%.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

3 Healthcare Stocks to Buy After the Market's Beating

3 Healthcare Stocks to Buy After the Market's Beating

Jim Cramer: Round Up the Usual Suspects

Jim Cramer: Round Up the Usual Suspects

Jim Cramer: We're Seeing Strong Recoveries in Good Stocks

Jim Cramer: We're Seeing Strong Recoveries in Good Stocks

How CVS Plans to Use Its Deal for Aetna to Transform Into Apple

How CVS Plans to Use Its Deal for Aetna to Transform Into Apple

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round